This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Carotid Atherosclerosis or Regional Anaesthesia Morbidity
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The aim of this prospective, randomised, controlled study is to compare the efficacy of ultrasound-guided intermediate cervical block to superficial block for carotid endarterectomy. Patients scheduled for carotide endarterectomy under regional anaesthesia (ropivacaine 4.75 mg/ml) are randomised into 2 groups according to the technique of anaesthesia performed: superficial cervical block (Control group) or, ultrasound guided intermediate cervical block (Echo group). Main outcome is cervical block success, defined by surgery performed under regional anaesthesia without supplemental topical lidocaine. Secondary outcomes are rate of conversion to general anaesthesia, total dose of supplemental topical lidocaine and block-related complications.

Provided treatments

  • Other: Ultrasound-guided administration of ropivacaine 4.75 mg/ml
  • Other: landmark based superfical ropivacaine 4.75 mg/ml injection

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01742845. The sponsor of the trial is Centre Hospitalier Universitaire de Besancon and it is looking for 86 volunteers for the current phase.
Official trial title:
Ultrasound-guided Intermediate Cervical Block Versus Superficial Cervical Block for Carotid : a Randomised Controlled Trial